WASHINGTON, D.C., January 19, 2018 /3BL Media/ - What do cervical cancer, Type 2 diabetes, and hypertension have in common? They are three diseases that are largely preventable, easily screened for/diagnosed, and highly treatable with known therapies. Addressing non-communicable diseases (NCDs) such as these, is a problem we can solve if we work together.
Novartis reaches agreement with Uganda to supply medicines that address the rapid rise of chronic diseases in the country. Uganda becomes the fifth country to launch the Novartis Access program.
July 6, 2017 /3BL Media/ -- We are pleased to announce that Novartis and the Ministry of Health of Uganda have signed a Memorandum of Understanding to implement Novartis Access in Uganda. Novartis Access medicines will be made available to patients in public health facilities through the National Medical Stores and through faith-based health services. The program will also cover capacity-building activities, including NCD prevention, diagnosis and treatment.
Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
By Dr. Ann Aerts, Head of the Novartis Foundation
Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.
Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.
May 12, 2017 /3BL Media/ -- We are pleased to announce that Novartis and the Ministry of National Health Services, Regulation and Coordination of the Islamic Republic of Pakistan have signed a Memorandum of Understanding to implement Novartis Access in Pakistan. Novartis Access medicines will be made available to the poorest population through hospitals under the Prime Minister’s National Health Insurance Program.
More than half the ASEAN region’s 630 million people are under age 30. Harald Nusser, Head of Novartis Social Business, says that to fight the rise of chronic disease in South East Asia we need to inform its youth on the importance of healthy lifestyles.
Access to healthcare is making controversial headlines these days as the report of the High-Level Panel on Access to Medicines set up by the Secretary-General of the United Nations was just released. We need to move away from ideological disputes about intellectual property and focus on how we can help patients receive the treatments they need now.
Any solution to the access challenge needs to consider the complex factors that affect access in developing countries. It would indeed be misleading and counter-productive to focus the access debate on patents. (...)
The Kenya Red Cross Society (KRCS) has announced a partnership with Novartis to improve access to prevention, treatment, and care of Non Communicable Diseases (NCDs) in Kenya. As part of the new partnership with Novartis, KRCS will train health workers, community volunteers and scale up screening at community and facility level for NCDs over the next three years.
Novartis Access is the 2016 winner of the "Prix Hermès de l'innovation" in the category “Improvement of the human condition”. Jürgen Brokatzky-Geiger, Global Head Corporate Responsibility, collected the award during the official ceremony in Paris on June 14.
The "Prix Hermès de l'innovation" recognizes companies or organizations which have excelled in integrating the best state of knowledge into products and services offering more satisfaction to individuals and society. It is owned by the European Institute for Creative Strategies and Innovation.
Blog written by Harald Nusser, Global Head Novartis Access
While the headlines might focus on Ebola or yellow fever, Africa is slowly winning the fight against infectious diseases. They will remain a challenge for decades to come, but the real threat of the future is expected to come from elsewhere: non-communicable diseases (NCDs) like diabetes, cardiovascular disease and cancer.